National Health (Originator Brand) Amendment Determination 2018 (No. 1) (PB 11 of 2018) (Cth)

PB 11 of 2018

National Health (Originator Brand) Amendment Determination 2018 (No. 1)

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under subsection 99ADB (6B) of the National Health Act 1953.

Dated        29 January 2018

______________________________________

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

1. Name of Determination

(1)     This Determination is the National Health (Originator Brand) Amendment Determination 2018 (No. 1).

(2)     This Determination may also be cited as PB 11 of 2018.

1. Commencement

This Determination commences on 1 February 2018.

1. Amendments to PB 100 of 2015

Schedule 1 amends the National Health (Originator Brand) Determination 2015 (PB 100 of 2015).

Schedule 1     Amendments

(section 3)

[1]   Schedule 1 (table item 1, 1A and 1B)

Repeal the items, substitute:

1	Abacavir with Lamivudine	Kivexa
1A	Abatacept	Orencia Orencia Clickject
1B	Acarbose	Glucobay 50 Glucobay 100
1C	Aciclovir	Zovirax Zovirax 200 mg Zovirax 800 mg